了解患有多发性硬化症的人的抑郁症:对最近文献的叙述性审查
相关实验视频
Updated: May 23, 2025

05:47
Animal Models of Depression - Chronic Despair Model CDM
Published on: September 23, 2021
7.1K
Amy B Sullivan1, Bryan Davis2, Julie Kidd3,4
1Cleveland Clinic, Cleveland, OH, USA. sulliva5@ccf.org.
Neurology and therapy
|March 27, 2025
概括
抑郁症在多发性硬化症 (MS) 中很常见,影响生活质量和治疗. 了解其原因和改善诊断对于更好地治疗MS患者至关重要.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 精神病学是一个精神病学.
背景情况:
- 多发性硬化症 (MS) 是一种慢性神经退行性和自身免疫性疾病,影响了100万美国成年人.
- 抑郁症是MS (pwMS) 患者最常见的并发症,显著影响生活质量和治疗坚持.
- 抑郁症的患病率随着MS的进展和残疾严重程度的增加而增加.
研究的目的:
- 审查最近关于pwMS中抑郁症的原因,危险因素和影响的研究.
- 讨论患者报告的评估pwMS中抑郁症的结果.
- 检查疾病修饰疗法和管理策略对pwMS抑郁症的影响.
主要方法:
- 关于多发性硬化症抑郁症的最新研究的文献综述.
- 对抑郁症的潜在原因,风险因素和影响的研究分析.
- 评估患者报告的结果和治疗疗效在 pwMS.
主要成果:
- 在pwMS中抑郁症的病因是多因素的,涉及大脑异常,遗传学和免疫学.
- 在pwMS中,抑郁症往往被诊断不足,治疗不足.
- 目前的药物和非药物治疗方法显示的效果很小或没有任何好处.
结论:
- 需要改进评估和诊断,以便在pwMS中有效管理抑郁症.
- 对MS抑郁症病理生理学的进一步研究是必不可少的.
- 对治疗抑郁症的综合方法对于MS患者的患者旅程至关重要.
相关概念视频
Depressive Disorders: Etiology
26
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
26
Depression: Overview
205
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
205
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Depressive Disorders: MDD and Dysthymia
29
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
29
Antidepressant Drugs: MAOIs and Other Agents
175
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
175
Diagnostic and Statistical Manual of Mental Disorders (DSM)
35
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
35

